We established that LARP1 exerts this pro-survival effect, at least in part, by post-transcriptionally promoting the expression of BCL2, a well-characterized oncogenic anti-apoptotic protein and a promoter of cancer cell survival (55). This evidence concerns the gene BCL2 and cancer.